DehydronuciferineCAS# 7630-74-2 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 7630-74-2 | SDF | Download SDF |
| PubChem ID | 821347 | Appearance | Powder |
| Formula | C19H19NO2 | M.Wt | 293.36 |
| Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| SMILES | CN1CCC2=CC(=C(C3=C2C1=CC4=CC=CC=C43)OC)OC | ||
| Standard InChIKey | JBGSWIBJAGBGOP-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C19H19NO2/c1-20-9-8-13-11-16(21-2)19(22-3)18-14-7-5-4-6-12(14)10-15(20)17(13)18/h4-7,10-11H,8-9H2,1-3H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Dehydronuciferine shows inhibitory of acetylcholinesterase with the IC50 of 25 ug/mL. |
| Targets | Beta Amyloid | AChR |
Dehydronuciferine Dilution Calculator
Dehydronuciferine Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.4088 mL | 17.0439 mL | 34.0878 mL | 68.1756 mL | 85.2195 mL |
| 5 mM | 0.6818 mL | 3.4088 mL | 6.8176 mL | 13.6351 mL | 17.0439 mL |
| 10 mM | 0.3409 mL | 1.7044 mL | 3.4088 mL | 6.8176 mL | 8.522 mL |
| 50 mM | 0.0682 mL | 0.3409 mL | 0.6818 mL | 1.3635 mL | 1.7044 mL |
| 100 mM | 0.0341 mL | 0.1704 mL | 0.3409 mL | 0.6818 mL | 0.8522 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Ophiopogonoside A
Catalog No.:BCN8595
CAS No.:791849-22-4
- Jasminoside B
Catalog No.:BCN8594
CAS No.:214125-04-9
- Cinobufaginol
Catalog No.:BCN8593
CAS No.:6691-83-4
- Licoflavone B
Catalog No.:BCN8592
CAS No.:91433-17-9
- Firmanoic acid
Catalog No.:BCN8591
CAS No.:107584-83-8
- Aaptamine
Catalog No.:BCN8590
CAS No.:85547-22-4
- Hydroquinidine
Catalog No.:BCN8589
CAS No.:1435-55-8
- Rubiayannone A
Catalog No.:BCN8588
CAS No.:517978-25-1
- Glyasperin C
Catalog No.:BCN8587
CAS No.:142474-53-1
- Sarracenin
Catalog No.:BCN8586
CAS No.:59653-37-1
- Platycodin D3
Catalog No.:BCN8585
CAS No.:67884-03-1
- Lucidin 3-O-primeveroside
Catalog No.:BCN8584
CAS No.:29706-59-0
- Licoflavone A
Catalog No.:BCN8597
CAS No.:61153-77-3
- Eriosematin
Catalog No.:BCN8598
CAS No.:168010-17-1
- Isoastragaloside IV
Catalog No.:BCN8599
CAS No.:136033-55-1
- Astraganoside
Catalog No.:BCN8600
CAS No.:1011711-05-9
- Rubipodanone A
Catalog No.:BCN8601
CAS No.:2170211-22-8
- Asperosaponin IV
Catalog No.:BCN8602
CAS No.:126778-93-6
- 9-Methymyrrhone
Catalog No.:BCN8603
CAS No.:1809980-22-0
- Uvarigranol C
Catalog No.:BCN8604
CAS No.:172104-04-0
- Saikosaponin I
Catalog No.:BCN8605
CAS No.:103629-71-6
- Toringin
Catalog No.:BCN8606
CAS No.:1329-10-8
- Lucidenic acid B
Catalog No.:BCN8607
CAS No.:95311-95-8
- Cnidicin
Catalog No.:BCN8608
CAS No.:14348-21-1
[Chemical constituents from leaves of Nelumbo nucifera].[Pubmed:23724680]
Zhongguo Zhong Yao Za Zhi. 2013 Mar;38(5):703-8.
To study the chemical constituents, twenty-seven compounds were isolated from the 70% ethanol extract from leaves of Nelumbo nucifera by modern chromatographic techniques. Their structures were identified as 10-octacosanol (1), beta-sitosterol (2), 1-undecanol (3), 1-eicosanol (4), daucosterol (5), 6'-hydroxy-4,4'-dimethoxychalcone (6), 3,7,8-trimethoxy-1-hydroxy-xanthone (7), rhamnetin-3-O-beta-D-glucopyranoside (8), chrysoeriol-7-O-beta-D-glucoside (9), quercetin-3-O-beta-D-glucopyranoside (10), quercetin-3-O-alpha-L-rhamnopyranosyl (11), hyperoside (12), quercetin-3-O-rutinoside (13), astragalin (14), isorhamnetin-3-O-alpha-L-rhamnopyranosyl-(1--> 6)-[alpha-D-lyxopyranosyl-(1 --> 2) -beta-D-glucopyranoside] (15), isorhamnetin-3-O-alpha-D-lyxopyranosyl-(1 --> 2) -beta-D-glucopyranoside (16), isorhamnetin-3-O-beta-D-glucopyranoside (17), isorhamnetin-3-O-alpha-L-rhamnopyranosyl-(1 --> 6)-beta-D-glucopyranoside (18), quercetin (19), kaempferol (20), Dehydronuciferine (21), roemerine (22), stigmast-7-en-3-O-beta-D-glucopyranoside (23), stigmast-7-en-3beta-ol (24), and benzene-1,2-diol (25) on the basis of spectral data analysis. Compounds 1, 6, 7, 8, 24 and 25 were isolated from this plant for the first time, and compounds 15-18 were isolated from the leaves for the first time. Compounds 6, 8, 10, 11, 13 and 15 showed inhibitory activities against beta amyloid (1-42) by A-beta aggregation method with inhibition rates of (63.99 +/- 24.29)%, (79.61 +/- 4.49)%, (49.96 +/- 12.61)%, (101.19 +/- 8.19)%, (88.41+/-6.76)% and (72.48 +/- 8.97)%, respectively.
